217 related articles for article (PubMed ID: 31046387)
1. Hereditary cancer syndromes, their testing and prevention.
Foretová L
Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
[TBL] [Abstract][Full Text] [Related]
2. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
3. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
[TBL] [Abstract][Full Text] [Related]
4. A review of inherited cancer susceptibility syndromes.
Brown GR; Simon M; Wentling C; Spencer DM; Parker AN; Rogers CA
JAAPA; 2020 Dec; 33(12):10-16. PubMed ID: 33234888
[TBL] [Abstract][Full Text] [Related]
5. The search for unaffected individuals with Lynch syndrome: do the ends justify the means?
Hampel H; de la Chapelle A
Cancer Prev Res (Phila); 2011 Jan; 4(1):1-5. PubMed ID: 21205737
[TBL] [Abstract][Full Text] [Related]
6. Genetic cancer predisposition syndromes among older adults.
Chavarri-Guerra Y; Slavin TP; Longoria-Lozano O; Weitzel JN
J Geriatr Oncol; 2020 Sep; 11(7):1054-1060. PubMed ID: 31980412
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.
Garutti M; Foffano L; Mazzeo R; Michelotti A; Da Ros L; Viel A; Miolo G; Zambelli A; Puglisi F
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239385
[TBL] [Abstract][Full Text] [Related]
8. Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic.
McFadden J; Hardesty J; Schroeder C; Vance GH; Boris RS
Urol Oncol; 2024 Mar; 42(3):72.e19-72.e25. PubMed ID: 38267302
[TBL] [Abstract][Full Text] [Related]
9. Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy.
Farncombe KM; Wong D; Norman ML; Oldfield LE; Sobotka JA; Basik M; Bombard Y; Carile V; Dawson L; Foulkes WD; Malkin D; Karsan A; Parkin P; Penney LS; Pollett A; Schrader KA; Pugh TJ; Kim RH;
Am J Hum Genet; 2023 Oct; 110(10):1616-1627. PubMed ID: 37802042
[TBL] [Abstract][Full Text] [Related]
10. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?
Kratz CP; Lupo PJ; Zelley K; Schienda J; Nichols KE; Stewart DR; Malkin D; Brodeur GM; Maxwell K; Plon SE; Walsh MF
Clin Cancer Res; 2024 May; 30(9):1733-1738. PubMed ID: 38411636
[TBL] [Abstract][Full Text] [Related]
11. Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.
Stoll J; Kupfer SS
Gastroenterol Hepatol (N Y); 2019 Sep; 15(9):462-470. PubMed ID: 31787853
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner.
Diez de Los Rios de la Serna C; Lluch-Canut MT; Fernández-Ortega MP
Semin Oncol Nurs; 2024 Jun; 40(3):151624. PubMed ID: 38575458
[TBL] [Abstract][Full Text] [Related]
13. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
[TBL] [Abstract][Full Text] [Related]
14. Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium.
Janatová M; Chvojka Š; Macháčková E; Soukupová J; Zemánková P; Nehasil P; Zavoral T; Hrušková L; Janíková KMK; Lhota F; Tavandzis S; Kleiblová P; Kleibl Z; Konzorcium C
Klin Onkol; 2023; 37(6):431-439. PubMed ID: 38158231
[TBL] [Abstract][Full Text] [Related]
15. Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
Weldon CB; Trosman JR; Liang SY; Douglas MP; Scheuner MT; Kurian A; Schaa KL; Roscow B; Erwin D; Phillips KA
J Genet Couns; 2022 Dec; 31(6):1394-1403. PubMed ID: 35900261
[TBL] [Abstract][Full Text] [Related]
16. Health and lifestyle behaviors among persons at risk of Lynch syndrome.
Burton AM; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER
Cancer Causes Control; 2010 Apr; 21(4):513-21. PubMed ID: 20012181
[TBL] [Abstract][Full Text] [Related]
17. Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study.
Katz SJ; Abrahamse P; Hodan R; Kurian AW; Rankin A; Tocco RS; Rios-Ventura S; Ward KC; An LC
JCO Oncol Pract; 2023 Jun; 19(6):e848-e858. PubMed ID: 36921235
[TBL] [Abstract][Full Text] [Related]
18. Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study.
Gilmore MJ; Knerr S; Kraft SA; Bulkley JE; Biesecker BB; Feigelson HS; Hunter JE; Jenkins CL; Kauffman TL; Lee SS; Liles EG; Mittendorf KF; Muessig KR; Porter KM; Rolf BA; Rope AF; Zepp JM; Anderson KP; Devine B; Joseph G; Leo MC; Goddard K; Wilfond BS
Public Health Genomics; 2024; 27(1):16-22. PubMed ID: 38142673
[No Abstract] [Full Text] [Related]
19. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
Grutters LA; Christiaans I
Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
[TBL] [Abstract][Full Text] [Related]
20. "The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome.
Palmquist AE; Koehly LM; Peterson SK; Shegog M; Vernon SW; Gritz ER
J Genet Couns; 2010 Oct; 19(5):473-86. PubMed ID: 20401527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
